Congleton Jon 4
4 · Mineralys Therapeutics, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2025-02-13+570,000→ 570,000 totalExercise: $10.20Exp: 2035-02-13→ Common Stock (570,000 underlying)
Footnotes (1)
- [F1]The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month anniversary following the date of grant.